For breast cancer survivors, tai chi decreases inflammation
the ONA take:
According to new research conducted by a team at University of California, Los Angeles, in Los Angeles, California, tai chi may reduce the risk of breast cancer recurrence by decreasing inflammation in patients who have had breast cancer.
For the 5-year, randomized clinical study conduced between 2007 and 2013, researchers enrolled 90 participants between 30 and 85 years old who have survived breast cancer. Researchers analyzed blood samples from the participants before and after participants began the tai chi routine.
Researchers say that tai chi decreases the levels of stress hormones in a person's body to the extent that the Chinese practice can decrease inflammation. Inflammation is often observed in breast cancer survivors following cancer treatment.
Researchers found that tai chi down-regulated the genes that ultimately cause inflammation. Anti-inflammatory effects observed with tai chi have also been seen when people use other forms of meditation. One patient who participated in the study reported an improvement in her insomnia as a result of practicing tai chi.
Tai chi may reduce the risk of breast cancer recurrence by decreasing inflammation.
UCLA researchers have discovered that the Chinese practice of tai chi can reduce inflammation in people who have had breast cancer, thereby reducing a risk factor for the recurrence of the cancer. Current research indicates that women diagnosed with breast cancer in the past 10 years are three times more likely to suffer from lack of sleep.
Insomnia can lead to increases in inflammation, which places breast cancer survivors at risk for cancer recurrence as well as cardiovascular disease.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|